| Literature DB >> 24257203 |
.
Abstract
Pakistan is one of three countries where transmission of indigenous wild poliovirus (WPV) has never been interrupted. This report describes polio eradication activities and progress in Pakistan during January 2012-September 2013 and updates previous reports. During 2012, 58 WPV cases were reported in selected areas, compared with 198 cases throughout the country in 2011; 52 WPV cases were reported during January-September 2013, compared with 54 cases during the same period in 2012. Of the 110 WPV cases reported since January 2012, 92 cases (84%) occurred in the conflict-affected Federally Administered Tribal Areas (FATA) and in security-compromised Khyber Pakhtunkhwa (KP) Province. WPV type 3 (WPV3) was isolated from only three persons with polio in a single district in 2012; the most recent case occurred in April 2012. During August 2012-September 2013, 52 circulating vaccine-derived poliovirus type 2 (cVDPV2) cases were detected, including 30 cases (58%) identified in FATA during January-September 2013. Approximately 350,000 children in certain districts of FATA have not received polio vaccine during supplementary immunization activities (SIAs) conducted since mid-2012 because local authorities have banned polio vaccination. In some other areas of Pakistan, SIAs have been compromised by attacks targeting polio workers that started in mid-2012. Further efforts to reach children in conflict-affected and security-compromised areas, including vaccinating at transit points and conducting additional short-interval-additional-dose (SIAD) SIAs as areas become accessible, will be necessary to prevent reintroduction of WPV into other areas of Pakistan and other parts of the world.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24257203 PMCID: PMC4585371
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586
FIGURE 1Number of cases of wild poliovirus types 1 (WPV1), 3 (WPV3), 1 and 3 (WPV1/WPV3), and circulating vaccine-derived poliovirus type 2 (cVDPV2), type of supplementary immunization activity conducted, and type of vaccine used, by month — Pakistan, 2010–2013*
Abbreviations: NID = national immunization days; SNID = subnational immunization days; mOPV = monovalent oral poliovirus vaccine; bOPV = bivalent oral poliovirus vaccine; tOPV = trivalent oral poliovirus vaccine.
* Data as of November 4, 2013.
FIGURE 2Cases of wild poliovirus types 1 (WPV1), 3 (WPV3), 1 and 3 (WPV1/WPV3), and circulating vaccine-derived poliovirus type 2 (cVDPV2) — Pakistan, January 2012–September 2013*†
Abbreviations: FATA = Federally Administered Tribal Areas; AJK = Azad Jammu and Kashmir.
* Data as of November 4, 2013.
† Each dot represents one poliovirus case. Dots drawn at random within districts.
Acute flaccid paralysis (AFP) surveillance indicators and reported cases of wild poliovirus (WPV) and circulating vaccine-derived poliovirus type 2 (cVDPV2), by province, period, and poliovirus type — Pakistan, January 2012–September 2013*
| Reported WPV cases | Reported cVDPV2 cases | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| ||||||||||
| AFP surveillance indicators (2012) | Period | Type | Period | ||||||||
|
|
|
|
| ||||||||
| Country/Area | No. of AFP cases | Nonpolio AFP rate | % with adequate specimens | Jan–Jun 2012 | Jul–Dec 2012 | Jan–Sep 2013 | WPV1 | WPV3 | WPV1/WPV3 | Jul–Dec 2012 | Jan–Sep 2013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| AJK, GB, ICT | 74 | 2.4 | 92 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| KP | 990 | 9.1 | 85 | 5 | 22 | 9 | 36 | 0 | 0 | 0 | 0 |
| FATA | 149 | 7.9 | 73 | 11 | 9 | 36 | 53 | 2 | 1 | 0 | 30 |
| Punjab | 2,407 | 5.8 | 91 | 2 | 0 | 3 | 5 | 0 | 0 | 0 | 0 |
| Balochistan | 205 | 5.0 | 83 | 3 | 1 | 0 | 4 | 0 | 0 | 15 | 2 |
| Sindh | 1,212 | 6.8 | 90 | 3 | 1 | 4 | 8 | 0 | 0 | 1 | 4 |
Abbreviations: AJK = Azad Jammu and Kashmir; GB = Gilgit-Baltistan; ICT = Islamabad Capital Territory; KP = Khyber Pakhtunkhwa (formerly Northwest Frontier Province); FATA = Federally Administered Tribal Areas.
Data as of November 4, 2013.
Per 100,000 children aged <15 years.
Two stool specimens collected ≥24 hours apart, both within 14 days of paralysis onset, and shipped on ice or frozen packs to a World Health Organization–accredited laboratory, arriving in good condition.
One case had coinfection with WPV1 and WPV3.